EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease

por Thieme, Karina, Majumder, Syamantak, Brijmohan, Angela S., Batchu, Sri N., Bowskill, Bridgit B., Alghamdi, Tamadher A., Advani, Suzanne L., Kabir, M. Golam, Liu, Youan, Advani, Andrew
Publicado 2017

HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease

por Brijmohan, Angela S., Batchu, Sri N., Majumder, Syamantak, Alghamdi, Tamadher A., Thieme, Karina, McGaugh, Sarah, Liu, Youan, Advani, Suzanne L., Bowskill, Bridgit B., Kabir, M. Golam, Geldenhuys, Laurette, Siddiqi, Ferhan S., Advani, Andrew
Publicado 2018